|
||
BRIEF DEFINITIVE REPORT |
CORRESPONDENCE Ranjan Sen: rs465z{at}nih.gov
|
|
|---|
T. Chakraborty's present address is Immune Disease Institute, Harvard Medical School, Boston, MA 02115.
Activation of a tissue-specific locus involves multiple epigenetic changes that are brought about by cis-regulatory sequences. However, the order or regulation of these changes is poorly understood for any mammalian gene. The β-globin gene cluster is one of the best characterized in terms of epigenetic regulation. In this locus, a region encompassing the four β-like genes is in a DNase I–sensitive configuration and associated with acetylated histones H3 and H4 in the erythroid lineage (1, 2). A cluster of DNase I hypersensitive sites (HS) comprise a locus control region that is essential for high-level transcription but not for erythroid-specific histone hyperacetylation or DNase I sensitivity (3–5). These observations provide evidence that transcription activation may be uncoupled from chromatin structural alterations that accompany locus activation.
The mouse Ig heavy chain (IgH) gene locus comprises variable (VH), diversity (DH), and joining (JH) gene segments and constant region exons that are dispersed over 2 Mb on chromosome 12. VH genes occupy
Tissue specificity and developmental timing of V(D)J recombination has been conceptualized in terms of the accessibility hypothesis, which posits that recombinase access is restricted to the appropriate antigen-receptor locus depending on the cell type (9). Recent studies implicate histone acetylation as an epigenetic mark of accessible loci (9, 10). At the IgH locus, this is reflected in only the DH-Cµ region being associated with acetylated histones before initiation of rearrangements (11–14). VH genes are hyperacetylated at a later developmental stage coincident with the second rearrangement step (11, 15). Thus, the pattern of histone acetylation closely parallels developmental regulation of IgH gene rearrangements.
Locus accessibility is established by cis-regulatory sequences that were originally identified as transcriptional promoters and enhancers. The DH-Cµ region contains two tissue-specific DNase I HS in the germline configuration (11). One marks the intron enhancer Eµ (16) (Fig. 1) and the other marks a region 5' to DQ52 that has promoter and enhancer activity (17). Genetic deletion of the DQ52 HS has little effect on IgH recombination (18, 19), whereas Eµ deletion reduces DH to JH recombination and blocks VH to DJH recombination (18, 20, 21). Although additional HSs have been identified in other parts of the IgH locus (22, 23), those that have been examined by genetic deletion appear not to contribute to V(D)J recombination.
1.5 Mb and are separated by a gap of 100 kb from 8–12 DH gene segments (6). Most DH gene segments are part of a tandem repeat (7, 8), and the 3'-most segment, DQ52, is positioned less than 1 kb 5' of the JH cluster. Functional IgH genes are assembled by site-specific recombination between VH, DH, and JH segments to create a V(D)J exon that encodes the antigen-binding variable domain of IgH. V(D)J recombination is developmentally regulated so that DH to JH recombination occurs first, followed by VH to DJH recombination.
|
As a step toward understanding how Eµ regulates IgH locus activation, we analyzed the effects of deleting the Eµ core on IgH chromatin structure, transcription, and recombination. For simplicity, we shall refer to this core deletion as Eµ deletion throughout this paper. Of the several histone modifications that characterize a fully active locus, we found that a subset were affected by Eµ, whereas others, such as H3K9 demethylation or H3K4 methylation, were not. Eµ deletion also resulted in reduced transcription and transcription-associated histone modifications, as well as loss of the DQ52 HS. We suggest that Eµ– alleles are trapped in a partially activated state that has not been previously described for any mammalian gene. Based on these observations, we propose that a hierarchy of epigenetic changes activate the IgH locus.
| RESULTS AND DISCUSSION |
|---|
|
|
|---|
Dimethylation of lysine 9 of histone H3 (H3K9me2) is a mark of inactive chromatin. In pro–T cells, or nonlymphoid lineage cells, H3K9me2 is present throughout the IgH locus. In pro–B cells, H3K9me2 is replaced by H3K9ac in all parts of the DH-Cµ region except the intervening DSP2 gene segments (7). We therefore investigated whether Eµ– alleles reverted to H3K9me2 modification in the absence of H3K9ac. The pattern of H3K9me2 was indistinguishable between Eµ+ or Eµ– pro–B cells (Fig. 1 C), revealing a discordance in the inverse relationship between H3K9ac and H3K9me2. We infer that loss of H3K9me2 is Eµ independent and gain of H3K9ac is Eµ dependent in primary pro–B cells. These observations indicate that Eµ– alleles are in a partially activated state.
This idea was further corroborated by analysis of suppressive histone modifications in pro–B cell lines. We found that DQ52, JH2, and JH4 amplicons that were associated with particularly high H3K9ac in Eµ+ cells contained 2–3-fold higher levels of H3K9me2 in Eµ– cells (Fig. 1 D). We note, however, that the locus was not restored to the fully repressed state seen in pro–T cells (Fig. 1 C) or to the level of H3K9me2 at the adjacent DSP2 repeats in Eµ+ pro–B cells. Dimethylation of lysine 27 of H3 (H3K27me2), another negative regulatory mark which has been proposed to be most evident in dividing cells (24), was also greatly elevated in the DQ52-Cµ region on Eµ– alleles (Fig. S2). These observations emphasize the state of the Eµ-deleted locus as a transitional intermediate between a fully "open" and a fully "closed" configuration.
Contribution of Eµ to DNase I sensitivity
We further investigated the effects of Eµ deletion using a PCR-based DNase I sensitivity assay to probe Eµ+ and Eµ– alleles in pro–B cell lines. To compare between samples, signals from IgH locus amplicons were normalized to an amplicon from the β-globin gene (25). Amplicons just 5' or 3' to the Eµ core were rapidly degraded in Eµ+ cells (Fig. 2, solid lines), which is indicative of the Eµ DNase I HS. Both amplicons were relatively insensitive in Eµ– cells (Fig. 2, dashed lines), indicating that Eµ core deletion abrogated the HS (Fig. 2, Eµ-5' and Eµ-3'). Classical DNase I hypersensitive site mapping by Southern blots confirmed this conclusion (unpublished data). Notably, DQ52 hypersensitivity was also substantially reduced in Eµ– cells, suggesting that it was Eµ dependent. Loss of Eµ also reduced DNase I sensitivity within JH gene segments and at Cµ but not at DFL16.1. The H3K9me2-bearing DSP genes remained DNase I insensitive in Eµ+ or Eµ– cells. We conclude that Eµ controls local chromatin accessibility and is critical for generation of the DQ52 HS.
|
Contribution of Eµ to sterile transcription
We used quantitative RT-PCR with primers as indicated (Fig. 3, top line) to assay transcription in the absence of Eµ. Consistent with earlier results (18, 20), Cµ-encompassing transcripts were reduced
7–10-fold in Eµ-deficient primary pro–B cells. Additionally, sense-oriented transcripts, as assayed by the DQ52 amplicon, as well as all antisense transcripts assayed by all other DH-amplicons (7, 8), were reduced 10–50-fold in Eµ– pro–B cells (Fig. 3 A). Reduced transcript levels coincided with reduced RNA polymerase II density on Eµ– alleles in pro–B cell lines (Fig. 3 B). We conclude that one function of Eµ is to recruit RNA Pol II to the IgH locus.
|
Because Eµ deletion affects VH to DJH recombination, we examined sterile VH gene transcription in Eµ+ and Eµ– primary pro–B cells. By quantitative RT-PCR, we found that sterile transcripts of proximal VH genes were substantially attenuated by loss of Eµ (Fig. 3 D); however, five amplicons representing upstream VHs were not significantly affected. For reference, VH7183.1b (also know as VH81X) is located
98 kb from DFL16.1 and Vox-1, a further 300 kb from VH7183.1b. VGK2, the most 3' gene in our set which is not affected by Eµ deletion, lies 420 kb 5' of Vox-1. We conclude that Eµ influences transcription of gene segments located >400 kb away.
Effect of Eµ deletion on DH to JH recombination
Earlier studies show that Eµ deletion results in five- to eightfold lower levels of DH to JH recombination (18, 20). These numbers were obtained from analyses of steady-state cell populations that are potentially subject to selection in vivo. To get an independent measure of DH recombination efficiency, we expressed RAG2 in two Eµ+ and one Eµ– RAG2-deficient pro–B cell lines by retroviral gene transfer and followed the levels of DH recombination as a function of time. We amplified genomic DNA from infected cells with 5' primers corresponding to either DFL16.1 or DSP gene segments and a common 3' primer downstream of JH3 (Fig. 4, top line). The amplified fragments were detected by Southern blotting after agarose gel fractionation. We observed easily detectable levels of DFL16-JH and DSP-JH rearrangements over the experimental time course in both Eµ+ cell lines (Fig. 4 A, lanes 1–4 and 13–16) but not in the Eµ– cell line (Fig. 4 A, lanes 7–10). Transduced RAG2 gene levels were comparable between all three cell lines, and an amplicon from the β-globin locus was used to ensure equal loading of genomic DNA. The mean of three independent infections is quantitated in Fig. 4 B. We conclude that Eµ deletion severely impairs DH to JH recombination in this assay. The greater reduction of DH to JH recombination in cell lines compared with primary cells may be because the chromatin structure of the IgH locus in continuously cycling Eµ– cells is skewed toward a suppressive state. This is reflected in lower levels of activating modifications H3K4me2 and H3K4me3 and higher levels of inactivating modifications H3K9me2 and H3K27me2 in these cells compared with primary cells. Alternatively, DJH junctions seen in the bone marrow of Eµ-deficient mice represents a gradual accumulation of recombinant alleles.
|
|
| MATERIALS AND METHODS |
|---|
|
|
|---|
ChIPs.
ChIPs were performed as previously described (7). Formaldehyde–cross-linked and sonicated chromatin from 107 cells was precleared with 5 µg of nonspecific IgG and immunoprecipitated with the requisite antibody (sources noted in Table S1) or an equal amount of nonspecific IgG. The coprecipitated DNA was purified and analyzed by real-time PCR using either previously described primers (7) or primers shown in Table S2.
Real-time PCR and ChIP data analysis.
Real-time PCR was performed as previously described (7) using the ABI Prism 7000 (Applied Biosystems). Abundance of target sequences in the immunoprecipitate relative to the input DNA (IN) was determined as previously described (35), where the relative abundance of the target sequence in the immunoprecipitate is 2–[Ct(IP)–Ct(IN)], and Ct is the cycle at which the sample reached a threshold value where PCR amplification was exponential.
DNase I sensitivity.
20 x 106 nuclei from RAG2–/– and Eµ–/–RAG2–/– cells were treated with varying concentrations of DNase I. 25 ng of purified genomic DNA was used in quantitative PCR assays performed in duplicate with primer pairs shown in Table S2. The proportion of DNA for each amplicon was normalized to the amount of intact β-globin alleles at each DNase I concentration using the formula 2amp[Ct(0)–Ct(n)]/2β[Ct(0)–Ct(n)], where Ct(0) is the cycle number for non-DNase I–treated samples at which an amplicon reaches the threshold for exponential amplification and Ct(n) is the cycle number for the sample treated with n units of DNase I. In this analysis, signal strength for β-globin amplicon would be 1 at all concentrations of DNase I. Sensitivity at the IgH locus was determined using two to three independent DNase I–treated samples from cells of each genotype.
Lentiviral transduction.
Lentiviral particles expressing RAG2 were generated as previously described (31) by transiently transfecting 293T cells with pWPI-RAG2 along with helper plasmids p
8.2R and pVSVG using FuGENE 6 (Roche). The supernatant containing the virus was collected at 48 and 72 h after transfection and concentrated by ultracentrifugation for 2 h at 25,000 rpm and 20°C over a 20% sucrose cushion. 4–6 x 106 cells were infected with freshly prepared control or RAG2-expressing lentivirus by spin inoculation in the presence of 10 µg/ml polybrene. Genomic DNA was isolated from the infected cells at different days after infection using the DNeasy tissue kit (QIAGEN). All procedures involving lentiviruses were performed under BSL2 conditions.
DJ rearrangement in RAG2-transduced cells.
45 ng of genomic DNA from transduced cells or 9 ng of genomic DNA from C57BL/6 bone marrow was amplified by 33 rounds of PCR using the HotStarTaq polymerase (QIAGEN). The forward primers hybridized 5' of either the DFL16.1 segment or the DSP2 segments and the reverse primer hybridized 3' of JH3 (Table S2). 25% of the PCR reaction was resolved by agarose gel electrophoresis, and rearrangement products were detected by Southern hybridization to an oligonucleotide probe that recognizes JH3. An amplicon from the mouse β-globin locus was used to normalize across samples, and level of RAG2 was ascertained using a primer pair that amplified part of the Rag2 gene not present in RAG2– cells (30 rounds of PCR amplification and 20% of the reaction used for Southern blotting).
Online supplemental material.
Supplemental figures show the effects of Eµ deletion on histone modifications assayed in Abelson mouse leukemia virus–transformed cell lines derived from the bone marrow of Eµ+ and Eµ– mice in a RAG2-deficient background. Table S1 lists the sources of antibodies and reagents used for ChIP and Table S2 lists primer sequences used in this work. Online supplemental material is available at http://www.jem.org/cgi/content/full/jem.20081621/DC1.
| Acknowledgments |
|---|
T. Perlot is supported by a Boehringer Ingelheim Fonds PhD scholarship. F.W. Alt is an investigator of the Howard Hughes Medical Institute. This work was supported by National Institutes of Health grant AI2047 (to F.W. Alt) and by the Intramural Research Program of the National Institute on Aging (Baltimore, MD).
The authors have no conflicting financial interests.
Submitted: 24 July 2008
Accepted: 2 April 2009
| REFERENCES |
|---|
|
|
|---|
Bulger, M., T. Sawado, D. Schubeler, and M. Groudine. 2002. ChIPs of the beta-globin locus: unraveling gene regulation within an active domain. Curr. Opin. Genet. Dev. 12:170–177.[CrossRef][Medline]
Felsenfeld, G., B. Burgess-Beusse, C. Farrell, M. Gaszner, R. Ghirlando, S. Huang, C. Jin, M. Litt, F. Magdinier, V. Mutskov, et al. 2004. Chromatin boundaries and chromatin domains. Cold Spring Harb. Symp. Quant. Biol. 69:245–250.
Bender, M.A., M. Bulger, J. Close, and M. Groudine. 2000. Beta-globin gene switching and DNase I sensitivity of the endogenous beta-globin locus in mice do not require the locus control region. Mol. Cell. 5:387–393.[CrossRef][Medline]
Farrell, C.M., A. Grinberg, S.P. Huang, D. Chen, J.G. Pichel, H. Westphal, and G. Felsenfeld. 2000. A large upstream region is not necessary for gene expression or hypersensitive site formation at the mouse beta-globin locus. Proc. Natl. Acad. Sci. USA. 97:14554–14559.
Schubeler, D., M. Groudine, and M.A. Bender. 2001. The murine beta-globin locus control region regulates the rate of transcription but not the hyperacetylation of histones at the active genes. Proc. Natl. Acad. Sci. USA. 98:11432–11437.
Chevillard, C., J. Ozaki, C.D. Herring, and R. Riblet. 2002. A three-megabase yeast artificial chromosome contig spanning the C57BL mouse Igh locus. J. Immunol. 168:5659–5666.
Chakraborty, T., D. Chowdhury, A. Keyes, A. Jani, R. Subrahmanyam, I. Ivanova, and R. Sen. 2007. Repeat organization and epigenetic regulation of the d(h)-cmu domain of the immunoglobulin heavy-chain gene locus. Mol. Cell. 27:842–850.[CrossRef][Medline]
Bolland, D.J., A.L. Wood, R. Afshar, K. Featherstone, E.M. Oltz, and A.E. Corcoran. 2007. Antisense intergenic transcription precedes Igh D-to-J recombination and is controlled by the intronic enhancer Emu. Mol. Cell. Biol. 27:5523–5533.
Mostoslavsky, R., F.W. Alt, and C.H. Bassing. 2003. Chromatin dynamics and locus accessibility in the immune system. Nat. Immunol. 4:603–606.[CrossRef][Medline]
Krangel, M.S., M.T. McMurry, C. Hernandez-Munain, X.P. Zhong, and J. Carabana. 2000. Accessibility control of T cell receptor gene rearrangement in developing thymocytes. The TCR alpha/delta locus. Immunol. Res. 22:127–135.[CrossRef][Medline]
Chowdhury, D., and R. Sen. 2001. Stepwise activation of the immunoglobulin mu heavy chain gene locus. EMBO J. 20:6394–6403.[CrossRef][Medline]
Johnson, K., C. Angelin-Duclos, S. Park, and K.L. Calame. 2003. Changes in histone acetylation are associated with differences in accessibility of V(H) gene segments to V-DJ recombination during B-cell ontogeny and development. Mol. Cell. Biol. 23:2438–2450.
Maes, J., L.P. ONeill, P. Cavelier, B.M. Turner, F. Rougeon, and M. Goodhardt. 2001. Chromatin remodeling at the Ig loci prior to V(D)J recombination. J. Immunol. 167:866–874.
Morshead, K.B., D.N. Ciccone, S.D. Taverna, C.D. Allis, and M.A. Oettinger. 2003. Antigen receptor loci poised for V(D)J rearrangement are broadly associated with BRG1 and flanked by peaks of histone H3 dimethylated at lysine 4. Proc. Natl. Acad. Sci. USA. 100:11577–11582.
Johnson, K., D.L. Pflugh, D. Yu, D.G. Hesslein, K.I. Lin, A.L. Bothwell, A. Thomas-Tikhonenko, D.G. Schatz, and K. Calame. 2004. B cell-specific loss of histone 3 lysine 9 methylation in the V(H) locus depends on Pax5. Nat. Immunol. 5:853–861.[CrossRef][Medline]
Nikolajczyk, B.S., W. Dang, and R. Sen. 1999. Mechanisms of mu enhancer regulation in B lymphocytes. Cold Spring Harb. Symp. Quant. Biol. 64:99–107.
Kottmann, A.H., B. Zevnik, M. Welte, P.J. Nielsen, and G. Kohler. 1994. A second promoter and enhancer element within the immunoglobulin heavy chain locus. Eur. J. Immunol. 24:817–821.[Medline]
Afshar, R., S. Pierce, D.J. Bolland, A. Corcoran, and E.M. Oltz. 2006. Regulation of IgH gene assembly: role of the intronic enhancer and 5'DQ52 region in targeting DHJH recombination. J. Immunol. 176:2439–2447.
Nitschke, L., J. Kestler, T. Tallone, S. Pelkonen, and J. Pelkonen. 2001. Deletion of the DQ52 element within the Ig heavy chain locus leads to a selective reduction in VDJ recombination and altered D gene usage. J. Immunol. 166:2540–2552.
Perlot, T., F.W. Alt, C.H. Bassing, H. Suh, and E. Pinaud. 2005. Elucidation of IgH intronic enhancer functions via germ-line deletion. Proc. Natl. Acad. Sci. USA. 102:14362–14367.
Sakai, E., A. Bottaro, L. Davidson, B.P. Sleckman, and F.W. Alt. 1999. Recombination and transcription of the endogenous Ig heavy chain locus is effected by the Ig heavy chain intronic enhancer core region in the absence of the matrix attachment regions. Proc. Natl. Acad. Sci. USA. 96:1526–1531.
Khamlichi, A.A., E. Pinaud, C. Decourt, C. Chauveau, and M. Cogne. 2000. The 3' IgH regulatory region: a complex structure in a search for a function. Adv. Immunol. 75:317–345.[Medline]
Pawlitzky, I., C.V. Angeles, A.M. Siegel, M.L. Stanton, R. Riblet, and P.H. Brodeur. 2006. Identification of a candidate regulatory element within the 5' flanking region of the mouse Igh locus defined by pro-B cell-specific hypersensitivity associated with binding of PU.1, Pax5, and E2A. J. Immunol. 176:6839–6851.
Baxter, J., S. Sauer, A. Peters, R. John, R. Williams, M.L. Caparros, K. Arney, A. Otte, T. Jenuwein, M. Merkenschlager, and A.G. Fisher. 2004. Histone hypomethylation is an indicator of epigenetic plasticity in quiescent lymphocytes. EMBO J. 23:4462–4472.[CrossRef][Medline]
McArthur, M., S. Gerum, and G. Stamatoyannopoulos. 2001. Quantification of DNaseI-sensitivity by real-time PCR: quantitative analysis of DNaseI-hypersensitivity of the mouse beta-globin LCR. J. Mol. Biol. 313:27–34.[CrossRef][Medline]
Hu, X., M. Bulger, M.A. Bender, J. Fields, M. Groudine, and S. Fiering. 2006. Deletion of the core region of 5' HS2 of the mouse beta-globin locus control region reveals a distinct effect in comparison with human beta-globin transgenes. Blood. 107:821–826.
Fang, X., P. Xiang, W. Yin, G. Stamatoyannopoulos, and Q. Li. 2007. Cooperativeness of the higher chromatin structure of the beta-globin locus revealed by the deletion mutations of DNase I hypersensitive site 3 of the LCR. J. Mol. Biol. 365:31–37.[CrossRef][Medline]
Pokholok, D.K., C.T. Harbison, S. Levine, M. Cole, N.M. Hannett, T.I. Lee, G.W. Bell, K. Walker, P.A. Rolfe, E. Herbolsheimer, et al. 2005. Genome-wide map of nucleosome acetylation and methylation in yeast. Cell. 122:517–527.[CrossRef][Medline]
Vakoc, C.R., M.M. Sachdeva, H. Wang, and G.A. Blobel. 2006. Profile of histone lysine methylation across transcribed mammalian chromatin. Mol. Cell. Biol. 26:9185–9195.
Matthews, A.G., A.J. Kuo, S. Ramon-Maiques, S. Han, K.S. Champagne, D. Ivanov, M. Gallardo, D. Carney, P. Cheung, D.N. Ciccone, et al. 2007. RAG2 PHD finger couples histone H3 lysine 4 trimethylation with V(D)J recombination. Nature. 450:1106–1110.[CrossRef][Medline]
Liu, Y., R. Subrahmanyam, T. Chakraborty, R. Sen, and S. Desiderio. 2007. A plant homeodomain in RAG-2 that binds hypermethylated lysine 4 of histone H3 is necessary for efficient antigen-receptor-gene rearrangement. Immunity. 27:561–571.[CrossRef][Medline]
Pray-Grant, M.G., J.A. Daniel, D. Schieltz, J.R. Yates, III, and P.A. Grant. 2005. Chd1 chromodomain links histone H3 methylation with SAGA- and SLIK-dependent acetylation. Nature. 433:434–438.[CrossRef][Medline]
Kurdistani, S.K., S. Tavazoie, and M. Grunstein. 2004. Mapping global histone acetylation patterns to gene expression. Cell. 117:721–733.[CrossRef][Medline]
Durant, M., and B.F. Pugh. 2006. Genome-wide relationships between TAF1 and histone acetyltransferases in Saccharomyces cerevisiae. Mol. Cell. Biol. 26:2791–2802.
Litt, M.D., M. Simpson, F. Recillas-Targa, M. Prioleau, and G. Felsenfeld. 2001. Transitions in histone acetylation reveal boundaries of three separately regulated neighboring loci. EMBO J. 20:2224–2235.[CrossRef][Medline]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| TABLE OF CONTENTS |
|